Seroprevalence of SARS-CoV2 in IBD Patients Treated with Biologic Therapy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Seroprevalence of SARS-CoV2 in IBD Patients Treated with Biologic Therapy
Authors
Keywords
-
Journal
Journal of Crohns & Colitis
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2020-11-18
DOI
10.1093/ecco-jcc/jjaa237
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A new coronavirus associated with human respiratory disease in China
- (2020) Fan Wu et al. NATURE
- Corticosteroids, but not TNF Antagonists, are Associated with Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results from an International Registry
- (2020) Erica J. Brenner et al. GASTROENTEROLOGY
- Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study
- (2020) Cristina Bezzio et al. GUT
- Performance of VivaDiag COVID‐19 IgM/IgG Rapid Test is inadequate for diagnosis of COVID‐19 in acute patients referring to emergency room department
- (2020) Irene Cassaniti et al. JOURNAL OF MEDICAL VIROLOGY
- A serological assay to detect SARS-CoV-2 seroconversion in humans
- (2020) Fatima Amanat et al. NATURE MEDICINE
- Antibody responses to SARS-CoV-2 in patients with COVID-19
- (2020) Quan-Xin Long et al. NATURE MEDICINE
- Meta-analysis of diagnostic performance of serological tests for SARS-CoV-2 antibodies up to 25 April 2020 and public health implications
- (2020) Saverio Caini et al. Eurosurveillance
- SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states, Germany, March to June 2020
- (2020) Bastian Fischer et al. Eurosurveillance
- Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation
- (2020) Emilie Seydoux et al. IMMUNITY
- Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
- (2020) Quan-Xin Long et al. NATURE MEDICINE
- Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Patients With Inflammatory Bowel Disease Under Biologic Treatment
- (2020) Lorenzo Norsa et al. GASTROENTEROLOGY
- Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans
- (2020) Jeffrey Seow et al. Nature Microbiology
- Persistence of Anti-SARS-CoV-2 Antibodies in Non-Hospitalized COVID-19 Convalescent Health Care Workers
- (2020) Margherita Bruni et al. Journal of Clinical Medicine
- Vedolizumab affects antibody responses to immunisation selectively in the gastrointestinal tract: randomised controlled trial results
- (2014) Tim Wyant et al. GUT
- Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease
- (2014) J.F. Rahier et al. Journal of Crohns & Colitis
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started